Pathology is transitioning from traditional microscopy to digital imaging and AI, reshaping the field's identity and ...
IFLScience on MSN
Experimental Alzheimer’s drug could have the power to halt disease before symptoms even start
A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.
An experimental drug called NU-9 has shown promise as an early intervention for Alzheimer's disease. | Drug Discovery And ...
In a joint study by researchers at the University of Rochester, US, and Indian researchers found that immune cells in the ...
Djagadou, K. , Tchala, A. , Nsoukpo, O. , Segniagbeto, K. , Agnegue, E. and Djibril, M. (2026) Future of the Elderly Person ...
Researchers showed that a severe drop in NAD+—a core energy molecule—drives Alzheimer’s pathology in both human brains and mouse models.
The APP ordered a bilateral diagnostic mammogram and left breast ultrasound that revealed extremely dense breast tissue, a ...
Scientists studying Alzheimer’s in African Americans have uncovered a striking genetic clue that may cut across racial lines.
This article describes a new method (VS-FPM) for analysis of unstained tissues based on the application of supervised machine learning to generate brightfield hematoxylin and eosin (H&E) images from ...
For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...
About 1 in 10 adults aged 70 or older may be eligible for antiamyloid therapy, finds the first population-based study to use ...
Artificial intelligence (AI) chatbots may be able to help interpret pathology reports for patients, but at this point they need clinician review before being delivered, researchers said. Among 1,134 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback